XML 72 R53.htm IDEA: XBRL DOCUMENT v3.25.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 12 Months Ended
Sep. 05, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2018
Dec. 31, 2016
Proceeds from issuance of common stock   $ 10,000,000    
Purchase obligation   479,000      
Income tax deficiency $ 1,900,000        
Pilaris Laboratories, LLC [Member]          
Finite-lived intangible asset, useful life         10 years
Intercompany agreements, description         As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the net income collected by the licensed products based on the following formula: Net Income = total income – cost of goods sold – advertising and operating expenses directly related to the marketing of the licensed products.
Percentage of net income         10.00%
Accrued expenses   0 5,000    
Payment for agreement   $ 5,000 $ 138,000    
M.ALPHABET, LLC [Member]          
Intercompany agreements, description       The Company shall pay Alphabet a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products. No amounts were earned or owed as of December 31, 2024.  
Share based compensation arrangement by share based payment award, expiration period       10 years  
Stock option to purchase shares       20,000  
Stock option exercise price       $ 2.50  
M.ALPHABET, LLC [Member] | Common Stock One [Member]          
Stock option to purchase shares       20,000  
Stock option exercise price       $ 2.50  
Proceeds from issuance of common stock       $ 7,500,000  
M.ALPHABET, LLC [Member] | Common Stock Two [Member]          
Stock option to purchase shares       20,000  
Stock option exercise price       $ 2.50  
Proceeds from issuance of common stock       $ 10,000,000.0  
M.ALPHABET, LLC [Member] | Common Stock Three [Member]          
Stock option to purchase shares       40,000  
Stock option exercise price       $ 3.75  
Proceeds from issuance of common stock       $ 20,000,000.0